Session 7D | From Lived Insight to Clinical Impact: Diverse Approaches to Methamphetamine Care
Tracks
.
| Wednesday, November 12, 2025 |
| 9:00 AM - 10:00 AM |
| C2.1 |
Details
Chair: Liam Acheson
Speaker
Dr Brendan Clifford
Senior Research Fellow
National Centre for Clinical Research on Emerging Drugs
Association between age of first methamphetamine use and childhood attention deficit hyperactivity disorder (ADHD) symptomatology – an exploratory study in a clinical trial cohort.
9:10 AM - 9:20 AMBiography
Dr Brendan Clifford is a Senior Research Fellow with the National Centre for Clinical Research in Emerging Drugs. Brendan is a clinician researcher who uses interdisciplinary methods to further health equity and enhance access to evidence-based healthcare.
Tariq Isaacs
Engagement Assistant
University Of Sydney
Development of Lived Experience Videos About Methamphetamine with Aboriginal and Torres Strait Islander Peoples
9:20 AM - 9:30 AMBiography
Dr Steph Kershaw
Senior Research Fellow
The Matilda Centre For Research In Mental Health And Substance Use
Development of Lived Experience Videos About Methamphetamine with Aboriginal and Torres Strait Islander Peoples
9:20 AM - 9:30 AMBiography
Tariq Isaacs is a Waliwan man from Coonamble and an Engagement Assistant at the Matilda Centre for Research in Mental Health and Substance Use. Tariq has worked in various roles as part of Indigenous based organisations , assisting on projects to improve the health outcomes for individuals, families, and communities.
Dr Krista Siefried
Clinical Research Lead, Senior Lecturer, Deputy Director
National Centre for Clinical Research on Emerging Drugs
Managing GHB withdrawal with early baclofen loading: A retrospective case series
9:30 AM - 9:40 AMBiography
Clinical Research Lead at NCCRED and Senior Lecturer at UNSW NDARC and SVHS Alcohol and Drug Services, with over 20 years’ experience. Her research focuses on novel treatments for emerging drug use, shaping global clinical guidelines and impacting policy to improve outcomes in addiction medicine and public health.
Dr David Newcombe
Associate Professor
University of the Sunshine Coast
Tū Whakaruruhau: The evaluation of treatment outcomes for methamphetamine dependence in Aotearoa New Zealand – design of a prospective longitudinal cohort study and longitudinal qualitative study.
9:40 AM - 9:45 AMBiography
David Newcombe is an Associate Professor in the School of Population Health, and Deputy Director of the Centre for Addiction Research, at University of Auckland. He has had over 20 years experience working in various clinical and education roles in the addiction sector in both Australia and New Zealand.
Jack Nagle
Olam Study Lived Experience Wg Chair
National Centre for Clinical Research on Emerging Drugs
Dr Cilla Zhou
Research & Partnerships Manager
National Centre for Clinical Research on Emerging Drugs
Learnings from the implementation of a Consumer Advisory Group for a nation-wide Randomised Placebo-Controlled Clinical Trial investigating a pharmacotherapy for methamphetamine withdrawal
9:45 AM - 9:50 AMBiography
Jack Nagle is a peer and addiction treatment professional. In 2014 he founded Real Drug Talk, which seeks to change the perceptions around addiction to reduce and eliminate stigma.
Dr Cilla Zhou is the Research & Partnerships Manager at NCCRED, where she supports NCCRED research activities by strengthening consumer collaborations.
APSAD 2025
Session 7D Q&A
9:50 AM - 10:00 AMBiography
Chair
Liam Acheson
Postdoctoral Fellow
National Centre for Clinical Research on Emerging Drugs